NCT02541760|CompletedPhase 3DMC
Loading search results
Sponsor study identifier
interventional
143
1 country
1
Study Start
April 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2015
Actual (reported)Study Completion
April 2015
Actual (reported)Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2014
Date type not reportedThis date has not been verified as actual or estimated.
March 2015
Actual (reported)April 2015
Actual (reported)September 2, 2015
Actual (reported)September 4, 2015
Actual (reported)Treatment response
Defined as complete, partial, or no response based on the physician examination
1 months
Drug side effects
1 month
4 ml monteleukast daily for one month
Inhaled mometasone 1 puff in each side of nose for one month
No intervention
4 ml monteleukast daily for one month
Inhaled mometasone 1 puff in each side of nose for one month
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hormozgan University of Medical Sciences
Bandar Abbas, Hormozgan, 097145-3388, Iran
Mulvaney CA, Galbraith K, Webster KE, Rana M, Connolly R, Tudor-Green B, Marom T, Daniel M, Venekamp RP, Schilder AG, MacKeith S. Topical and oral steroids for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023 Dec 13;12(12):CD015255. doi: 10.1002/14651858.CD015255.pub2.
Rahmati MB, Safdarian F, Shiroui B, Zare S, Sadeghi N. Montelukast versus inhaled mometasone for treatment of otitis media with effusion in children: A randomized controlled trial. Electron Physician. 2017 Jul 25;9(7):4890-4894. doi: 10.19082/4890. eCollection 2017 Jul.
Hamidreza Mahboobi, M.D
Hormozgan University of Medical Sciences
143 participants (actual enrollment reported by the registry).
First Submitted
September 2, 2015
First Posted
September 4, 2015
Study Start
April 2014
Date type not reportedThis date has not been verified as actual or estimated.
A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)
Contact the study team to confirm eligibility.
Primary Completion
March 2015
Actual (reported)Study Completion
April 2015
Actual (reported)Last Updated
September 4, 2015
Record last verified: 2015-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: